PHG
Konink Phil Sp ADR (PHG)
NYSE
$30.39+$0.19 (+0.64%)
Price as of Nov 12, 2026 9:06 AM EST
  • $29.5B
    Market Cap
  • 10.66%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 17
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Philips: 3 Key Takeaways for Long-Term Investors

Philips reported 8% equipment order intake growth in Q3 2026, driven by hospitals consolidating vendors and prioritizing clinical value over price. The company is scaling its Enterprise Monitoring as a Service subscription model with revenues nearly doubling year-over-year, while productivity savings of EUR 170 million in Q3 are offsetting inflation pressures. Management remains on track for mid-single-digit comparable sales growth CAGR through 2028 and mid-teen adjusted EBITA margins by 2028.

11/06/2026, 8:22 PM • The Motley Fool

Medical Imaging Workstations Market Size, Share, Trends, and Forecast Analysis - Global Forecast to 2036 | AI, Cloud, and Enterprise Imaging Drive 7.3% CAGR and USD 12.55 Billion Opportunity

The global medical imaging workstations market is estimated at USD 6.20 billion in 2026 and projected to reach USD 12.55 billion by 2036, expanding at a CAGR of 7.3%. Growth is driven by rising chronic disease prevalence, digital imaging infrastructure investments, AI integration, and enterprise imaging adoption. Key challenges include high costs, cybersecurity risks, and radiologist shortages, while opportunities exist in cloud-based solutions and emerging markets.

11/06/2026, 10:59 AM • GlobeNewswire

Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab

Royal Philips announced U.S. commercial availability of the HyperVue Integrated System, a fixed single-room configuration combining DeepOCT+NIRS imaging and X1-FFR physiology assessment for coronary interventions. The system is designed to streamline cathlab workflows by eliminating setup steps and keeping advanced imaging and physiology tools readily available. Philips will showcase this alongside its broader portfolio including IntraSight Plus at TCT 2026.

10/30/2026, 4:00 PM • GlobeNewswire

Banco Comercial Português, S.A. informs on the notification of securities transactions - Rectification

Banco Comercial Português, S.A. issued notifications regarding securities transactions and provided interim reports on its Share Buy-Back Programme. The article also includes unrelated corporate announcements from VOA National Services, Philips, and legal notices regarding O-I Glass.

10/30/2026, 3:40 PM • GlobeNewswire

Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform

Royal Philips announced the launch of UniGuide 3D Live Guidance, a CE-marked solution that integrates CT-derived planning information directly into live procedures on its Azurion image-guided therapy platform. The technology enables physicians to access pre-procedural CT insights during interventions in cardiology and vascular procedures, supporting more informed treatment decisions. UniGuide is available in CE-marked markets from October 23, 2026, but not yet in the United States.

10/29/2026, 5:00 AM • GlobeNewswire

Global Computed Tomography (CT) Market by Application, Technology, Care Setting, and Product: Five-Year Forecast | Photon-Counting Scanners and AI Breathe New Life Into a Mature CT Market

The global computed tomography market is experiencing significant innovation driven by photon-counting technology, AI integration, and mobile imaging systems. Despite market maturity and coverage challenges, these advances are expanding access to CT imaging across hospitals, clinics, and emerging care settings including veterinary and dental applications. Key manufacturers are competing on slice count, AI capabilities, and spectral imaging technologies.

10/23/2026, 10:00 AM • GlobeNewswire

Global Digital Health and Remote Patient Monitoring Strategic Market Report, 2026-2031 | 20.2% CAGR to $80.8 Billion as Connected Care and Wearables Scale

The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, expanding at a 20.2% CAGR. Growth is driven by rising chronic disease management demand, expanding reimbursement coverage, and maturing wearable sensor technology, enabling a shift from episodic facility-centered care to continuous connected care models.

10/21/2026, 5:00 AM • GlobeNewswire

Digital X-ray Market - Global and Regional Analysis and Forecast, 2026-2036 | Mobile Imaging, AI Workflows, and Detector Innovation Drive Growth to $9.90 Billion

The global digital X-ray market is projected to grow from $5.79 billion in 2025 to $9.90 billion by 2036, expanding at a 5.09% CAGR. Growth is driven by the transition from analog to digital systems, adoption of mobile and retrofit solutions, AI-enabled workflows, and detector innovations. North America leads the market, while Asia-Pacific presents significant expansion opportunities. Key challenges include workforce shortages and integration complexity.

10/16/2026, 6:00 AM • GlobeNewswire

Global Mobile X-ray Systems Market Analysis and Forecast, 2026-2036 | AI-Enabled Digital Imaging and Asia-Pacific Growth Drive a $4.00 Billion Market by 2036

The global mobile X-ray systems market is projected to grow from $2.06 billion in 2025 to $4.00 billion by 2036, with a CAGR of 6.30%. Growth is driven by rising chronic disease prevalence, increasing hospitalization rates, and demand for point-of-care imaging. Digital systems dominate with 91.57% market share, while handheld/ultra-portable systems are the fastest-growing segment. Asia-Pacific leads regional growth at 7.43% CAGR, followed by North America and Europe.

10/16/2026, 5:58 AM • GlobeNewswire

Global Mobile C-Arm Market Analysis and Forecast, 2026-2036 | Market to Reach $3.71 Billion as Minimally Invasive Surgery, AI, and 3D Imaging Drive 5.35% CAGR

The global mobile C-arm market is projected to grow from $2.09 billion in 2025 to $3.71 billion by 2036, expanding at a 5.35% CAGR. Growth is driven by rising adoption of minimally invasive surgery, AI integration, 3D imaging, and aging populations. North America leads the market, with hospitals as the primary end-users. Key challenges include high capital costs and shortage of skilled professionals, while advanced storage and archiving capabilities present significant growth opportunities.

10/16/2026, 5:54 AM • GlobeNewswire

Saudi Arabia Air Purifier Market Size, Share, Trends, and Forecast 2026-2034 | Smart HEPA Adoption and Vision 2030 Projects Drive 7.06% CAGR and US$369.22 Million Opportunity

Saudi Arabia's air purifier market is projected to grow from US$199.82 million in 2025 to US$369.22 million by 2034, with a CAGR of 7.06%. Growth is driven by increasing awareness of indoor air quality, frequent dust storms, rapid urbanization, respiratory health concerns, and Vision 2030 infrastructure projects. Portable HEPA purifiers dominate the market, with Riyadh and Jeddah leading regional demand. Key challenges include high purchase prices, filter replacement costs, and consumer knowledge gaps.

10/06/2026, 4:53 AM • GlobeNewswire

Pacemaker/Defibrillator Lead Extraction Kit Market Forecast - 2034 | $1.92 Billion Opportunity Fueled by Minimally Invasive Care and Rising CIED Infections

The global Pacemaker/Defibrillator Lead Extraction Kit market is projected to grow from USD 1.03 billion in 2025 to USD 1.92 billion by 2034, expanding at a CAGR of 7.2%. Growth is driven by rising CIED implantation volumes, increasing device-related infections, aging populations, and the shift toward minimally invasive procedures. Mechanical extraction systems lead with 46% market share, while hospitals account for 85% of revenue. North America dominates with 44% market share, while Asia-Pacific is expected to record the fastest regional growth.

09/30/2026, 4:55 AM • GlobeNewswire

Cardiorespiratory Assessment Units Market Poised for Growth Through 2035 as Advanced Technologies and Expanding Clinical Applications Create New Opportunities

The global Cardiorespiratory Assessment Units Market is projected to grow from USD 1.48 billion in 2025 to USD 2.98 billion by 2035, expanding at a CAGR of 7.23%. Growth is driven by rising prevalence of COPD and heart failure, innovation in portable AI-enabled systems, and expanding remote care applications. However, high equipment costs and staffing requirements remain challenges. North America leads with 35.12% market share.

09/25/2026, 4:58 AM • GlobeNewswire

Exor Press Release - Buyback Launch

Exor N.V. has launched a €500 million share buyback program to reduce share capital, starting with a first tranche of €125 million expected to be completed by end of November 2026. The program will be executed through a discretionary buyback agreement with a financial institution in compliance with market regulations.

09/23/2026, 2:30 AM • GlobeNewswire

Software as a Medical Device Market Set for Rapid Growth Through 2034 as AI Innovation, Digital Health Adoption, and Regulatory Advances Reshape the Competitive Landscape

The global Software as a Medical Device (SaMD) market is projected to grow from USD 2.10 billion in 2025 to USD 8.90 billion by 2034, expanding at a CAGR of 17.4%. Growth is driven by AI-enabled diagnostics, digital therapeutics, cloud-based deployment, and maturing regulatory pathways. Diagnostic and screening software leads with 42% market share, while radiology applications dominate at 34%. North America holds 45% of the market, with Asia-Pacific expected to record the fastest growth.

09/17/2026, 6:51 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$29.81
$30.30
$30.20
1-Year Range
$23.81
$32.91
$30.20
Latest Close$30.20
Change
-$0.21 (-0.70%)
Volume1,773,697
Market Cap$29.5B
Shares Outstanding977.6M
P/E (TTM)32.47
Diluted EPS (TTM)$0.93
Enterprise Value$26.3B

Information as of 11/11/2026

Company Profile

KONINKLIJKE PHILIPS NV
KONINKLIJKE PHILIPS NV
https://www.philips.com
$29.5B
Market Cap
$1.1B
Net Income
Sector: Healthcare
Industry: Medical Devices
Philips Center, Amsterdam, Netherlands, 1077 WV
31 20 597 7777

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Key Executives

  • Roy Willem Odilia Jakobs
  • Charlotte Hanneman
  • Marnix J. van Ginneken
  • Paulus A. Stoffels
  • Laura Matz

Current Ownership Distribution

  • Institutions1.3B (84.06%)
  • Mutual Funds250.3M (15.94%)
  • Insiders0 (0.00%)
  • Other0 (0.00%)